Feasibility of iNKT cell and PD-1+CD8+ T cell-based immunotherapy in patients with lung adenocarcinoma: Preliminary results of a phase I/II clinical trial.

Cheng, Xiaobo; Wang, Jing; Qiu, Chenli; Jin, Yanling; Xia, Bili; Qin, Ran; Hu, Huiliang; Yan, Jia; Zhang, Xiaoyan; Xu, Jianqing

Cheng, Xiaobo; Wang, Jing; Qiu, Chenli; Jin, Yanling; Xia, Bili; Qin, Ran; Hu, Huiliang; Yan, Jia; Zhang, Xiaoyan; Xu, Jianqing.

Afiliación

Cheng X; Shanghai Public Health Clinical Center & Institutes of Biomedical Sciences, Fudan University, Shanghai 201508, P.R. China; Clinical Research Center, Obstetrics & Gynecology Hospital of Fudan University, Shanghai 200011, P.R. China.
Wang J; Shanghai Public Health Clinical Center & Institutes of Biomedical Sciences, Fudan University, Shanghai 201508, P.R. China.
Qiu C; Shanghai Public Health Clinical Center & Institutes of Biomedical Sciences, Fudan University, Shanghai 201508, P.R. China.
Jin Y; Shanghai Public Health Clinical Center & Institutes of Biomedical Sciences, Fudan University, Shanghai 201508, P.R. China.
Xia B; Shanghai Public Health Clinical Center & Institutes of Biomedical Sciences, Fudan University, Shanghai 201508, P.R. China.
Qin R; Shanghai Public Health Clinical Center & Institutes of Biomedical Sciences, Fudan University, Shanghai 201508, P.R. China.
Hu H; Shanghai Public Health Clinical Center & Institutes of Biomedical Sciences, Fudan University, Shanghai 201508, P.R. China.
Yan J; Shanghai Public Health Clinical Center & Institutes of Biomedical Sciences, Fudan University, Shanghai 201508, P.R. China.
Zhang X; Shanghai Public Health Clinical Center & Institutes of Biomedical Sciences, Fudan University, Shanghai 201508, P.R. China. Electronic address: zhangxiaoyan@fudan.edu.cn.
Xu J; Shanghai Public Health Clinical Center & Institutes of Biomedical Sciences, Fudan University, Shanghai 201508, P.R. China. Electronic address: xujianqing@fudan.edu.cn.

Clin Immunol ; 238: 108992, 2022 05.

Article en En | MEDLINE | ID: mdl-35367396

Asunto(s)

Adenocarcinoma del Pulmón; Antineoplásicos Inmunológicos; Neoplasias Pulmonares; Células T Asesinas Naturales; Antineoplásicos Inmunológicos/uso terapéutico; Protocolos de Quimioterapia Combinada Antineoplásica/uso terapéutico; Linfocitos T CD8-positivos/patología; Estudios de Factibilidad; Humanos; Factores Inmunológicos/uso terapéutico; Inmunoterapia; Neoplasias Pulmonares/tratamiento farmacológico; Células T Asesinas Naturales/patología; Receptor de Muerte Celular Programada 1

Palabras clave

Immunotherapy; Lung adenocarcinoma; Natural killer T-cells

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Células T Asesinas Naturales / Antineoplásicos Inmunológicos / Adenocarcinoma del Pulmón / Neoplasias Pulmonares Límite: Humans Idioma: En Revista: Clin Immunol Asunto de la revista: ALERGIA E IMUNOLOGIA Año: 2022 Tipo del documento: Article Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google